Statements (15)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Eli_Lilly_and_Company
|
gptkbp:acquisitionYear |
2018
|
gptkbp:focus |
immuno-oncology
|
gptkbp:foundedYear |
2012
|
gptkbp:founder |
Peter Van Vlasselaer
|
gptkbp:headquartersLocation |
gptkb:Redwood_City,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Armo Biosciences
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
pegilodecakin
|
gptkbp:status |
defunct
|
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:ARMO
|
gptkbp:bfsParent |
gptkb:Beth_Seidenberg
|
gptkbp:bfsLayer |
7
|